CA2182904A1 - Utilisation des derives de 2-[4-(azolylbutyl)piperazinyl(methyl)] benzimidazole pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme - Google Patents

Utilisation des derives de 2-[4-(azolylbutyl)piperazinyl(methyl)] benzimidazole pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme

Info

Publication number
CA2182904A1
CA2182904A1 CA002182904A CA2182904A CA2182904A1 CA 2182904 A1 CA2182904 A1 CA 2182904A1 CA 002182904 A CA002182904 A CA 002182904A CA 2182904 A CA2182904 A CA 2182904A CA 2182904 A1 CA2182904 A1 CA 2182904A1
Authority
CA
Canada
Prior art keywords
benzimidazole
ethoxyethyl
butyl
methyl
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002182904A
Other languages
English (en)
French (fr)
Inventor
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2182904A1 publication Critical patent/CA2182904A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002182904A 1994-12-08 1995-12-06 Utilisation des derives de 2-[4-(azolylbutyl)piperazinyl(methyl)] benzimidazole pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme Abandoned CA2182904A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9414766A FR2727865B1 (fr) 1994-12-08 1994-12-08 Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
FR94/14766 1994-12-08
PCT/EP1995/004884 WO1996017609A1 (fr) 1994-12-08 1995-12-06 Utilisation des derives de 2-[4-(azolylbutyl)piperazinyl(methyl)] benzimidazole pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme

Publications (1)

Publication Number Publication Date
CA2182904A1 true CA2182904A1 (fr) 1996-06-13

Family

ID=9469596

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002182904A Abandoned CA2182904A1 (fr) 1994-12-08 1995-12-06 Utilisation des derives de 2-[4-(azolylbutyl)piperazinyl(methyl)] benzimidazole pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme

Country Status (9)

Country Link
EP (1) EP0741571A1 (pt)
JP (1) JPH09508923A (pt)
AU (1) AU714581B2 (pt)
BR (1) BR1100852A (pt)
CA (1) CA2182904A1 (pt)
ES (1) ES2105986B1 (pt)
FR (1) FR2727865B1 (pt)
WO (1) WO1996017609A1 (pt)
ZA (1) ZA9510435B (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
JPH0383924A (ja) * 1989-08-28 1991-04-09 Kanebo Ltd 経皮投与用組成物
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
FR2668150B1 (fr) * 1990-10-17 1994-11-18 Theramex Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.

Also Published As

Publication number Publication date
EP0741571A1 (fr) 1996-11-13
BR1100852A (pt) 1999-10-13
ES2105986A1 (es) 1997-10-16
AU4261196A (en) 1996-06-26
AU714581B2 (en) 2000-01-06
ES2105986B1 (es) 1998-07-01
FR2727865B1 (fr) 1997-07-18
WO1996017609A1 (fr) 1996-06-13
JPH09508923A (ja) 1997-09-09
FR2727865A1 (fr) 1996-06-14
ZA9510435B (en) 1996-06-14

Similar Documents

Publication Publication Date Title
US11759467B2 (en) Treatment
CN1250290C (zh) 基于抗胆碱能有效的化合物及β－模拟物的新颖药物组合物
AU3462599A (en) Pulmonary and nasal delivery of raloxifene
CN1635923A (zh) 增强一氧化氮吸入剂的疗效
WO2006023944A2 (en) Pulmonary delivery of inhibitors of phosphodiesterase type 5
FR2801506A1 (fr) Utilisation d'une poudre seche comprenant du formoterol pour la preparation d'un medicament inhalable
US10813893B2 (en) Compositions and methods for the treatment and prevention of chronic hypoxemia and dyspnea
US20200237815A1 (en) Methods for treatment of lung damage and for inhibition of lung fibrosis
JP2002527473A (ja) フォルモテロールを含む貯蔵可能な活性物質濃縮物
US11191759B2 (en) Therapeutic agent for fibrosis
US20210369732A1 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4-OXAZEPANE-2-CARBOXAMIDE
RU2685706C2 (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
CN115397417A (zh) 含有噻托溴铵和奥达特罗的可吸入溶液制剂
CN106474479B (zh) 血管紧张素受体拮抗剂和磷酸肌酸钠的复合物及其用途
KR20210070968A (ko) 닌테다닙 또는 이의 약학적으로 허용가능한 염의 미세입자를 포함하는 흡입용 건조분말 제형
CA2182904A1 (fr) Utilisation des derives de 2-[4-(azolylbutyl)piperazinyl(methyl)] benzimidazole pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
JP2608227B2 (ja) 抗糖尿病薬
JP2002532405A (ja) オピオイド吸入製剤
DE60022070T2 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
EP0542979B1 (fr) Composition therapeutique pour liberation prolongee de magnesium
TWI762449B (zh) 噴霧器用組成物
US20200016102A1 (en) Methods for the treatment of chronic hypoxemia and inhibiting lung fibrosis in patients with pulmonary fibrosis with and without COPD
CH665637A5 (fr) 5-(3-n-butyloxalylaminophenyl)tetrazole comme agent antiasthmatique, composition le contenant et procede de preparation de la composition.
JP2839827B2 (ja) ウレアーゼ阻害剤
US20090022915A1 (en) Particle and preparation containing the particle

Legal Events

Date Code Title Description
FZDE Dead